Sharp Decline Following Fiscal Forecast

C3.ai experienced a dramatic drop in stock value, plummeting by more than 30% this Monday. The downturn came after the AI firm announced its revenue projections for the first quarter of fiscal year 2026, estimating between $70.2 million and $70.4 million. This marks a significant decrease from the previous year's $87.2 million in the same quarter, with similar trends expected in net loss.

CEO's Health Impact on Company Performance

Adding to the company's challenges, CEO Thomas M. Siebel disclosed that his ongoing health issues, including an autoimmune disease, have limited his involvement in the sales process. "My health has prevented me from participating in the sales process as actively as I have in the past," Siebel admitted, highlighting the personal hurdles affecting the company's operations.

Organizational Changes Amidst Turmoil

In response to these challenges, Siebel announced several structural adjustments within the organization. Notably, Rob Schilling has been appointed as the new Chief Commercial Officer (CCO), signaling a strategic shift aimed at revitalizing the company's sales and commercial strategies.

By 9:35 am ET, C3.ai's shares had fallen by 31.97%, trading at $15.0550, reflecting the market's reaction to the latest developments.